Seagen Stockholders Approve Acquisition by Pfizer

Following a special meeting of its stockholders, Seagen Inc. (Nasdaq: SGEN) today announced that its stockholders voted to approve a proposal to adopt the ...

May 31, 2023 | Wednesday | News
GE HealthCare's New Deep Learning Solution Cleared by FDA for Enhanced PET/CT Image Quality, Reinforcing AI Leadership

A type of artificial intelligence (AI), Deep Learning (DL) technology can advance medical imaging capabilities by providing more robust, accurate, and da...

May 31, 2023 | Wednesday | News
Hansa Begins Global Phase 3 Trial for Imlifidase in Anti-GBM Disease

Søren Tulstrup, President and CEO, Hansa Biopharma said, "This is an exciting next step in the development of imlifidase and for patients with anti-...

May 30, 2023 | Tuesday | News
Novavax's Nuvaxovid™ Receives Positive CHMP Opinion for EU Marketing Authorization in COVID Prevention

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant,  announced that Nuvaxovid&tra...

May 29, 2023 | Monday | News
Merck's Commitment to Enhancing Cancer Outcomes at ASCO 2023

Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023...

May 29, 2023 | Monday | News
Lexicon's INPEFA™ (sotagliflozin) FDA Approved for Heart Failure Treatment

INPEFA reduced the risk of total occurrence of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits by 33% compared to ...

May 29, 2023 | Monday | News
Iovance Biotherapeutics' Lifileucel for Advanced Melanoma Receives FDA Acceptance

First Potential Approval of an Individualized, One-Time Cell Therapy  for Patients with Advanced Melanoma Iovance Biotherapeutics, Inc. (NASDAQ: IOVA...

May 29, 2023 | Monday | Regulatory
Illumina shareholders re-elect eight of nine Illumina directors

Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that based on the preliminary results of its 2023 ...

May 26, 2023 | Friday | News
KEYTRUDA® + LENVIMA® Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma

After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581...

May 26, 2023 | Friday | News
Takeda and HUTCHMED's Fruquintinib NDA for Metastatic Colorectal Cancer Gets Priority Review

— Prescription Drug User Fee Act (PDUFA) Target Action Date set for November 30, 2023 — — NDA includes results from the Phase III FRESCO...

May 26, 2023 | Friday | News
West Opens Cutting-edge Facility in Singapore

West Pharmaceutical Services, Inc. (West), a global leader in  innovative solutions for injectable drug administration, today inaugurates its newly ad...

May 25, 2023 | Thursday | News
Azenta Partners with Lupus Research Alliance to Advance Lupus Research and Drug Discovery

Azenta, Inc. (Nasdaq: AZTA)  announced it has been selected by the Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics to s...

May 25, 2023 | Thursday | News
Biopharma Leaders Unite at Veeva Summit to Drive Innovation for Industry and Patients

Veeva Systems (NYSE: VEEV)  announced that leaders from Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, and Syneos Health are among the speak...

May 25, 2023 | Thursday | News
Biocon Reports Impressive Q4FY23 Results: Revenue Soars 59% to Rs 3,929 Cr; Biosimilars Surge 114%

Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company,  today announced its consolidated financial results ...

May 24, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close